Fundz

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development

PUBLIC · ANIXOct 07, 2024

Position

Chief Development Officer

Company

Anixa Biosciences

Pamela Garzone
pgarzone@anixa.com
San JoseBiotechnologyHealth CareTherapeutics

Description

Anixa Biosciences announced the appointment of Suyasha Gupta as Senior Director of Clinical Development, who will work closely with Dr. Pamela Garzone, Chief Development Officer, to oversee the Company's ongoing Phase 1 breast cancer vaccine and Phase 1 ovarian cancer CAR-T therapy clinical trials, as well as the upcoming Phase 2 breast cancer vaccine clinical trial.

Quick answer

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development (October 7, 2024). Anixa Biosciences is based in San Jose, California, United States.

What did Anixa Biosciences announce on October 7, 2024?
Anixa Biosciences announced the appointment of Suyasha Gupta as Senior Director of Clinical Development, who will work closely with Dr. Pamela Garzone, Chief Development Officer, to oversee the Company's ongoing Phase 1 breast cancer vaccine and Phase 1 ovarian cancer CAR-T therapy clinical trials, as well as the upcoming Phase 2 breast cancer vaccine clinical trial.
What does Anixa Biosciences do?
Anixa Biosciences, Inc. is a biotechnology company focused on developing innovative therapies for various types of cancers and infectious diseases.
Where is Anixa Biosciences based?
Anixa Biosciences is based in San Jose, California, United States.
Which similar companies made leadership changes around the same time?
Oak Hill Bio (October 7, 2024), Nuvation Bio (October 7, 2024), Immunome Inc. (October 8, 2024) and Anavo Therapeutics (October 9, 2024) also announced leadership changes within 45 days of Anixa Biosciences.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Anixa Biosciences, and when

A new leader at Anixa Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Anixa Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Anixa Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Anixa Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Anixa Biosciences

Location

San Jose, California, United States

About

Anixa Biosciences, Inc. is a biotechnology company focused on developing innovative therapies for various types of cancers and infectious diseases. The company is primarily engaged in the research and development of immunotherapies and vaccines, with key products including a novel cancer vaccine and T-cell therapies. Anixa operates in the global biotechnology market, serving healthcare sectors by addressing significant unmet medical needs. The firm is headquartered in San Jose, California and is publicly traded on the NASDAQ under the symbol 'ANIX'. Recently, Anixa has emphasized on advancing its clinical studies and establishing partnerships to enhance its product pipeline.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Anixa Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Suyasha
Likely contact at this company
••••••••@••••••••

See Suyasha's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Anixa Biosciences's next move

Learn about Strategic plan

Anixa Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.